Tumor gene testing urged to tell if drug targets your cancer
Share
Tweet
July 7, 2017
WASHINGTON (AP) — Colon cancer. Uterine cancer. Pancreatic cancer. Whatever the tumor, the more gene mutations lurking inside, the better chance your immune system has to fight back.
That's the premise behind the recent approval of a landmark drug, the first cancer therapy ever cleared based on a tumor's genetics instead of the body part it struck first. Now thousands of patients with worsening cancer despite standard treatment can try this immunotherapy — as long as genetic testing of the tumor shows they're a candidate.
"It's like having a lottery ticket," said Johns Hopkins oncologist Dr. D...
For access to this article please
sign in or
subscribe.
Reader Comments(0)